When formulating BCS II drugs, traditional methods focused on solubility and dissolution tests, assuming permeability remained unchanged. However, research shows that modifying solubilizing agents can influence API permeability by altering the amount of free API available for absorption through epithelial cells. Understanding these effects is crucial for optimizing drug formulations and improving bioavailability.

‍